Piper Jaffray analyst Matt O'Brien reiterated an Overweight rating and $80 price target on NuVasive after the company announced that it had appointed Matthew Harbaugh as CFO, effective immediately, while also reiterating its guidance for fiscal 2019. O'Brien said he was "surprised" by the announcement, and will "certainly miss" previous CFO Rajesh Asarpota and the financial direction he brought to the company. However, the analyst said he is "encouraged" by Harbaugh's pedegree and his previous working relationship with NuVasive CEO Barry. O'Brien added that he expects "good things" from Harbaugh in the future and is not worried by the announcement.